Musculoskeletal Adverse Events Following BCMA CAR T-Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune Correlates
2026 · Transplantation and Cellular Therapy · 0 citations
https://doi.org/10.1016/j.jtct.2026.02.009
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
329
Citations
9
h-index
9
i10-index
Amber Feng is an academic researcher from Duke Medical Center. The author has contributed to research in topics: Histone Deacetylase Inhibitors Research & CAR-T cell therapy research & Chemokine receptors and signaling. The author has an h-index of 9, co-authored 17 publications.
Click to start Chat